Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Rong

Showing results (391-400 of 482) with videos related to

Pageof 49
Sort By:
Zhonghua Nei Ke Za Zhi|January 19, 2013
[The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation]Lan-ping Xu, Dai-hong Liu, Kai-yan Liu, et al.
Cancer Communications (London, England)|October 24, 2022
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessmentChen-Hua Yan, Yu Wang, Yu-Qian Sun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomesXiao-Dong Mo, Jun Kong, Ting Zhao, et al.
Blood Cell Therapy|June 9, 2025
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantationLing Ma, Si-Qi Li, Wei Han, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Chinese Medical Journal|October 28, 2011
Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantationXiao-ying Qin, Guo-xuan Li, Ya-zhen Qin, et al.
Zhonghua Nei Ke Za Zhi|July 26, 2011
[The efficacy and safety of second allogeneic hematopoietic stem cell transplantation for post-transplant hematologic malignancies relapse]Yu-Hong Chen, Lan-Ping Xu, Huan Chen, et al.
Leukemia & Lymphoma|March 26, 2015
Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapyYa-Zhen Qin, Lan-Ping Xu, Huan Chen, et al.
Blood Science (Baltimore, Md.)|September 27, 2024
Pre-transplantation levels of lysine (K)-specific methyltransferase 2A (<i>KMT2A</i>) partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantationDao-Xing Deng, Xiao-Hang Ma, Ze-Hua Wu, et al.
Bone Marrow Transplantation|April 6, 2026
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapseXiao-Tong Chen, Ze-Chang Shi, Yu Wang, et al.
Pageof 49

Showing results (391-400 of 482) with videos related to

Sort By:
Pageof 49
Zhonghua Nei Ke Za Zhi|January 19, 2013
[The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation]Lan-ping Xu, Dai-hong Liu, Kai-yan Liu, et al.
Cancer Communications (London, England)|October 24, 2022
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessmentChen-Hua Yan, Yu Wang, Yu-Qian Sun, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomesXiao-Dong Mo, Jun Kong, Ting Zhao, et al.
Blood Cell Therapy|June 9, 2025
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantationLing Ma, Si-Qi Li, Wei Han, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Chinese Medical Journal|October 28, 2011
Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantationXiao-ying Qin, Guo-xuan Li, Ya-zhen Qin, et al.
Zhonghua Nei Ke Za Zhi|July 26, 2011
[The efficacy and safety of second allogeneic hematopoietic stem cell transplantation for post-transplant hematologic malignancies relapse]Yu-Hong Chen, Lan-Ping Xu, Huan Chen, et al.
Leukemia & Lymphoma|March 26, 2015
Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapyYa-Zhen Qin, Lan-Ping Xu, Huan Chen, et al.
Blood Science (Baltimore, Md.)|September 27, 2024
Pre-transplantation levels of lysine (K)-specific methyltransferase 2A (<i>KMT2A</i>) partial tandem duplications can predict relapse of acute myeloid leukemia patients following haploidentical donor hematopoietic stem cell transplantationDao-Xing Deng, Xiao-Hang Ma, Ze-Hua Wu, et al.
Bone Marrow Transplantation|April 6, 2026
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapseXiao-Tong Chen, Ze-Chang Shi, Yu Wang, et al.
Pageof 49